氨己烯酸片(喜保宁)一盒多少钱

It is an analogue of gamma-aminobutyric acid (GABA), which can specifically bind to GABA aminotransferase and irreversibly, leading to an increase in GABA concentration in the brain, thus exerting anti-epileptic effects. Clinically, vigabatrin tablets (vigabatrin) are used to treat epilepsy in which other anti-epileptic drugs are ineffective, especially partial seizures; vigabatrin tablets (vigabatrin) can also treat infantile spasms (West syndrome, West syndrome).

Vigabatrin tablets (Vigabatrin) are irreversible GABA transaminase inhibitors that can increase the levels of GABA in the brain and cerebrospinal fluid. They were developed in the 1980s. In 1989, vigabatrin tablets (Vigabatrin) were approved in the UK. On August 21, 2009, the U.S. FDA approved Vigabatrin Tablets (Vigabatrin) as a monotherapy for pediatric patients 1 month to 2 years old, where the potential benefits of infantile spasms outweigh the potential risk of vision loss, and as an adjuvant (additional) treatment (CPS) for adult patients with refractory complex partial epilepsy. On January 16, 2019, the FDA approved the launch of a generic version of vigabatrin tablets (Sabril). Vigabatrin tablets (Vigabatrin) are sold under the brand name Sabril in Canada, Mexico, and the United Kingdom.

How much does a box of vigabatrin tablets (Vigabatrin) cost?

It is understood that vigabatrin tablets are only available in a few countries, and the vigabatrin tablets (vigabatrin) produced by Sanofi in France are cost-effective. Its specifications are 500 mg 

The incidence of visual field defects is high (approximately one third) among patients. This often occurs after using Vigabatrin for several months to several years. Visual field defects can be severe, which can have real consequences for the patient. Most patients with visual field loss have no obvious symptoms.

Recommended related hot articles: /newsDetail/84525.html